Genocea Biosciences (NASDAQ:GNCA) Research Coverage Started at StockNews.com
StockNews.com began coverage on shares of Genocea Biosciences (NASDAQ:GNCA – Free Report) in a report issued on Tuesday morning. The firm issued a sell rating on the biotechnology company’s stock. Genocea Biosciences Stock Performance Genocea Biosciences has a fifty-two week low of $0.00 and a fifty-two week high of $0.00. The company has a current […]
More Stories
Ninety One North America Inc. Lowers Position in Alphabet Inc. (NASDAQ:GOOGL)
Ninety One North America Inc. cut its holdings in shares of Alphabet Inc. (NASDAQ:GOOGL – Free Report) by 7.3% during...
Wall Street Zen Upgrades Houlihan Lokey (NYSE:HLI) to “Buy”
Houlihan Lokey (NYSE:HLI – Get Free Report) was upgraded by Wall Street Zen from a “hold” rating to a “buy”...
Alphabet Inc. (NASDAQ:GOOGL) Shares Bought by EULAV Asset Management
EULAV Asset Management grew its stake in shares of Alphabet Inc. (NASDAQ:GOOGL – Free Report) by 2.8% in the 1st...
Alphabet Inc. (NASDAQ:GOOGL) Stake Raised by Family Capital Management Inc.
Family Capital Management Inc. grew its holdings in shares of Alphabet Inc. (NASDAQ:GOOGL – Free Report) by 3.1% during the...
Brown Advisory Inc. Sells 569 Shares of Xylem Inc. (NYSE:XYL)
Brown Advisory Inc. lowered its position in Xylem Inc. (NYSE:XYL – Free Report) by 5.0% in the first quarter, HoldingsChannel.com...
Corning (GLW) and Its Competitors Head-To-Head Analysis
Corning (NYSE:GLW – Get Free Report) is one of 28 publicly-traded companies in the “Communications Components” industry, but how does...